Literature DB >> 10037143

Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition.

N Barboule1, C Lafon, P Chadebech, S Vidal, A Valette.   

Abstract

Activation of protein kinase C (PKC) inhibits cell cycle progression at the G1/S and G2/M transitions. We found that phorbol 12-myristate 13-acetate (PMA) induced upregulation of p21, not only in MCF-7 cells arrested in the G1 phase as previously shown, but also in cells delayed in the G2 phase. This increase in p21 in cells accumulated in the G1 and G2/M phases of the cell cycle after PMA treatment was inhibited by the PKC inhibitor GF109203X. This indicates that PKC activity is required for PMA-induced p21 upregulation and cell cycle arrest in the G1 and G2/M phases of the cell cycle. To further assess the role of p21 in the PKC-induced G2/M cell cycle arrest independently of its G1 arrest, we used aphidicolin-synchronised MCF-7 cells. Our results show that, in parallel with the inhibition of cdc2 activity, PMA addition enhanced the associations between p21 and either cyclin B or cdc2. Furthermore, we found that after PMA treatment p21 was able to associate with the active Tyr-15 dephosphorylated form of cdc2, but this complex was devoid of kinase activity indicating that p21 may play a role in inhibition of cdc2 induced by PMA. Taken together, these observations provide evidence that p21 is involved in integrating the PKC signaling pathway to the cell cycle machinery at the G2/M cell cycle checkpoint.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037143     DOI: 10.1016/s0014-5793(99)00022-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21CIP1.

Authors:  S Dangi; F M Chen; P Shapiro
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

2.  Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.

Authors:  Caroline E Nunes-Xavier; Ari Elson; Rafael Pulido
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

3.  p21(WAF1) is associated with CDK2 and CDK4 protein during HL-60 cell differentiation by TPA treatment.

Authors:  J W Cho; Y W Jeong; K S Kim; J Y Oh; J C Park; J C Lee; W K Baek; S I Suh; M H Suh
Journal:  Cell Prolif       Date:  2001-10       Impact factor: 6.831

4.  Differential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 breast cancer cells to phorbol ester.

Authors:  Caroline E Nunes-Xavier; Céline Tárrega; Rocío Cejudo-Marín; Jeroen Frijhoff; Asa Sandin; Arne Ostman; Rafael Pulido
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

5.  Protein kinase C mediates phosphorylation of the regulatory light chain of myosin-II during mitosis.

Authors:  O Varlamova; A Spektor; A R Bresnick
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

6.  NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1).

Authors:  A Op De Beeck; J Sobczak-Thepot; H Sirma; F Bourgain; C Brechot; P Caillet-Fauquet
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cells.

Authors:  Xiaodong Zhou; Sung-Hoon Kim; Ling Shen; Hyo-Jung Lee; Changyan Chen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Protein kinase D isozymes activation and localization during mitosis.

Authors:  Romeo Papazyan; Michael Doche; Richard T Waldron; Enrique Rozengurt; Mary Pat Moyer; Osvaldo Rey
Journal:  Exp Cell Res       Date:  2008-07-26       Impact factor: 3.905

9.  p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress.

Authors:  Fabienne Baus Charrier-Savournin; Marie-Thérèse Château; Véronique Gire; John Sedivy; Jacques Piette; Vjekoslav Dulic
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

10.  MAPK pathway activation delays G2/M progression by destabilizing Cdc25B.

Authors:  Puji Astuti; Tanya Pike; Charlotte Widberg; Elizabeth Payne; Angus Harding; John Hancock; Brian Gabrielli
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.